gyki 52466 has been researched along with Depression, Endogenous in 2 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, B | 1 |
Hou, Y | 1 |
Zhu, M | 1 |
Bao, H | 1 |
Nie, J | 1 |
Zhang, GY | 1 |
Shan, L | 1 |
Yao, Y | 1 |
Du, K | 1 |
Yang, H | 1 |
Li, M | 1 |
Zheng, B | 1 |
Xu, X | 1 |
Xiao, C | 1 |
Du, J | 1 |
Farley, S | 1 |
Apazoglou, K | 1 |
Witkin, JM | 1 |
Giros, B | 1 |
Tzavara, ET | 1 |
2 other studies available for gyki 52466 and Depression, Endogenous
Article | Year |
---|---|
3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.
Topics: Animals; Antidepressive Agents; Benzodiazepines; Deoxyadenosines; Depressive Disorder; Disease Model | 2016 |
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depr | 2010 |